Literature DB >> 11738778

Mild hypothermia induced by a helmet device: a clinical feasibility study.

S Hachimi-Idrissi1, L Corne, G Ebinger, Y Michotte, L Huyghens.   

Abstract

STUDY
OBJECTIVE: To test the feasibility and the speed of a helmet device to achieve the target temperature of 34 degrees C in unconscious after out of hospital cardiac arrest (CA).
METHODS: Patients with cardiac arrest due to asystole or pulseless electrical activity (PEA) who remained unconscious after restoration of spontaneous circulation (ROSC) were enrolled in the study and randomised into two groups: a normothermic group (NG) and a hypothermic group (HG). Bladder and tympanic temperature were monitored every 15 min. A helmet device was used to induce mild hypothermia in the HG. Later on, the effect of mild hypothermia on the haemodynamics, electrolytes, lactate, arterial pH, CaO2, CvO2 and O2 extraction ratio were analysed and compared to the values obtained from the NG.
RESULTS: Thirty patients were eligible for the study, 16 were randomised into the HG and 14 were randomised into the NG. The median tympanic temperature at admission in both groups was 35.5 degrees C (range: 33.3-38.5 degrees C) and the median tympanic temperature after haemodynamic stabilisation was 35.7 degrees C (range: 33.6-38.2 degrees C). In the HG, the core and the central target temperature of 34 degrees C were achieved after a median time of 180 and 60 min, respectively after ROSC. At the start of the study, no significant differences between the NG and HG were seen. At the end of the study, lactate concentration and O2 extraction ratio were significantly lower in the HG; however the CvO2 was significantly lower in the NG.
CONCLUSIONS: Mild hypothermia induced by a helmet device was feasible, easy to perform, inexpensive and effective, with no increase in complications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738778     DOI: 10.1016/s0300-9572(01)00412-9

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  66 in total

Review 1.  Therapeutic hypothermia for acute neurological injuries.

Authors:  Lucia Rivera-Lara; Jiaying Zhang; Susanne Muehlschlegel
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  [Targeted temperature management in critical care : current 2011 recommendations].

Authors:  N Jahn; U X Kaisers
Journal:  Anaesthesist       Date:  2012-06       Impact factor: 1.041

3.  Treatment of resistant fever: new method of local cerebral cooling.

Authors:  Susanne Mink; Urs Schwarz; Regina Mudra; Christoph Gugl; Jürg Fröhlich; Emanuela Keller
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

4.  Therapeutic applications of hypothermia in cerebral ischaemia.

Authors:  Bruno P Meloni; Frank L Mastaglia; Neville W Knuckey
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

Review 5.  [Therapeutic hypothermia after cardiac arrest].

Authors:  E Popp; F Sterz; B W Böttiger
Journal:  Anaesthesist       Date:  2005-02       Impact factor: 1.041

Review 6.  [Therapeutic hypothermia].

Authors:  A Schneider; E Popp; P Teschendorf; B W Böttiger
Journal:  Anaesthesist       Date:  2008-02       Impact factor: 1.041

7.  Therapeutic hypothermia after cardiac arrest: performance characteristics and safety of surface cooling with or without endovascular cooling.

Authors:  Alexander C Flint; J Claude Hemphill; David C Bonovich
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 8.  The use of pre-hospital mild hypothermia after resuscitation from out-of-hospital cardiac arrest.

Authors:  Francis Kim; Michele Olsufka; Graham Nichol; Michael K Copass; Leonard A Cobb
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

Review 9.  Hypothermia for cardiac arrest.

Authors:  David M Greer
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

Review 10. 

Authors:  J P Nolan; C D Deakin; J Soar; B W Böttiger; G Smith; M Baubin; B Dirks; V Wenzel
Journal:  Notf Rett Med       Date:  2006-02-01       Impact factor: 0.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.